Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2015 Sep 3;3(5):e01007-15. doi: 10.1128/genomeA.01007-15

Draft Genome Sequence of a Clinical Isolate of Serratia marcescens, Strain AH0650_Sm1

Yu Wan a,b,, Claire L Gorrie a,b,c, Adam Jenney d, Mirjana Mirceta d, Kathryn E Holt a,b,
PMCID: PMC4559744  PMID: 26337895

Abstract

Serratia marcescens strain AH0650_Sm1 is a clinical multidrug-resistant isolate from Australia. Here, we report its annotated draft genome comprising 20 contigs. We identified chromosomal antimicrobial resistance genes including a tet(41) variant, an aac(6′)-Ic variant, ampC, a metallo-beta-lactamase, and several putative multidrug efflux pumps, as well as a novel prophage.

GENOME ANNOUNCEMENT

The Gram-negative, facultative anaerobic and motile bacillus Serratia marcescens is an opportunistic human pathogen and a member of the Enterobacteriaceae (1, 2). It is ubiquitous in nature and has been recognized since the 1950s as an etiological agent of nosocomial infections (3), including bacteremia, pneumonia, meningitis, myocarditis, endocarditis, respiratory tract infections, urinary tract infections, and wound infections (46). Moreover, S. marcescens can pose a serious obstacle to antimicrobial treatment of infections due to its intrinsic and acquired resistance to a wide range of antimicrobials (7, 8).

S. marcescens strain AH0650_Sm1 was isolated from the sputum of a pneumonia patient at the Alfred Hospital Intensive Care Unit in Melbourne, Australia, on 20 March 2014. Antimicrobial susceptibility tests via the Vitek 2 system (bioMérieux, France) showed that AH0650_Sm1 was resistant to ampicillin (MIC 16), amoxicillin-clavulanic acid (MIC ≥32), ticarcillin-clavulanic acid (MIC ≤8), piperacillin-tazobactam (MIC ≤4), tobramycin (MIC 4), nitrofurantoin (MIC 256), and cefazolin (MIC ≥64); intermediately resistant to cefoxitin (MIC 16); and susceptible to amikacin (MIC ≤2), ceftriaxone (MIC ≤1), ceftazidime (MIC ≤1), cefepime (MIC ≤1), meropenem (MIC ≤0.25), gentamicin (MIC ≤1), ciprofloxacin (MIC ≤0.25), norfloxacin (MIC ≤0.5), trimethoprim (MIC ≤0.5), and trimethoprim-sulfamethoxazole (MIC ≤20). The unit of all MICs is µg/ml.

Whole-genomic DNA was extracted using phenol-chloroform and the Phase Lock Gel protocol (5PRIME), with some minor adaptations, and a barcoded library was prepared using the Nextera XT kit (Illumina, USA). Paired-end sequencing was performed at the Australian Genome Research Facility with the Illumina HiSeq 2500 system, generating 1,858,192 read pairs (2 × 125 bp) yielding 90× coverage. Reads were filtered for an average Phred quality ≥30 and assembled de novo using SPAdes version 3.5.0 (9) with k-mer lengths of 21, 33, 55, 77, and 99. SSPACE version 3.0 (10) was used for scaffolding, and GapFiller version 1.10 (11) was used for filling gaps. Contigs were further extended and reordered using AlignGraph version 27062014 (12) and ABACAS version 1.3.1 (13), respectively, with reference to the finished chromosome sequence of S. marcescens Db11 (RefSeq accession no. NZ_HG326223). Contigs shorter than 200 bp were removed. The final assembly was annotated using Prokka version 1.11 (14). Antimicrobial resistance genes and plasmid replicons were screened using SRST2 (15) with databases from ARG-ANNOT (16) and PlasmidFinder (17). PHAST (18) was used for identifying prophage regions. These genomic features were further investigated using nucleotide and protein BLAST.

This draft genome contains 5,201,657 bp assembled into 20 contigs with an N50 of 946 kbp. The genomic annotation includes 4,734 protein coding sequences, 88 tRNA genes, 22 rRNA genes, and one tmRNA gene. Genes related to antimicrobial resistance were identified, including variants of tet(41) and tetR(41) (8), an aac(6′)-Ic (19) variant, ampC, ampR, and those encoding a metallo-beta-lactamase and several multidrug efflux pumps. A putative novel prophage (31.8 kbp) was identified, which shared 75% identity with Salmonella phage FSL SP-004 (RefSeq GenBank accession no. NC_021774) along 60% of its length. No plasmid replicon was detected.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number LFJS00000000. The version described in this paper is the first version, LFJS00000000.1.

ACKNOWLEDGMENTS

This work was supported by the NHMRC of Australia (project grant no. 1043822, fellowship no. 1061409 to K.E.H.) and the Victorian Life Sciences Computation Initiative (grant no. VR0082).

Footnotes

Citation Wan Y, Gorrie CL, Jenney A, Mirceta M, Holt KE. 2015. Draft genome sequence of a clinical isolate of Serratia marcescens, strain AH0650_Sm1. Genome Announc 3(5):e01007-15. doi:10.1128/genomeA.01007-15.

REFERENCES

  • 1.Szewzyk U, Szewzyk R, Stenström TA. 1993. Growth and survival of Serratia marcescens under aerobic and anaerobic conditions in the presence of materials from blood bags. J Clin Microbiol 31:1826–1830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Petty NK, Foulds IJ, Pradel E, Ewbank JJ, Salmond GP. 2006. A generalized transducing phage (ϕIF3) for the genomically sequenced Serratia marcescens strain db11: a tool for functional genomics of an opportunistic human pathogen. Microbiology 152:1701–1708. doi: 10.1099/mic.0.28712-0. [DOI] [PubMed] [Google Scholar]
  • 3.Wheat RP, Zuckerman A, Rantz LA. 1951. Infection due to chromobacteria: report of eleven cases. AMA Arch Intern Med 88:461–466. doi: 10.1001/archinte.1951.03810100045004. [DOI] [PubMed] [Google Scholar]
  • 4.Wilfert JN, Barrett FF, Kass EH. 1968. Bacteremia due to Serratia marcescens. N Engl J Med 279:286–289. doi: 10.1056/NEJM196808082790604. [DOI] [PubMed] [Google Scholar]
  • 5.Hejazi A, Falkiner FR. 1997. Serratia marcescens. J Med Microbiol 46:903–912. doi: 10.1099/00222615-46-11-903. [DOI] [PubMed] [Google Scholar]
  • 6.Mills J, Drew D. 1976. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med 84:29–35. doi: 10.7326/0003-4819-84-1-29. [DOI] [PubMed] [Google Scholar]
  • 7.Mahlen SD. 2011. Serratia infections: from military experiments to current practice. Clin Microbiol Rev 24:755–791. doi: 10.1128/CMR.00017-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Thompson SA, Maani EV, Lindell AH, King CJ, McArthur JV. 2007. Novel tetracycline resistance determinant isolated from an environmental strain of Serratia marcescens. Appl Environ Microbiol 73:2199–2206. doi: 10.1128/AEM.02511-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. 2011. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics 27:578–579. doi: 10.1093/bioinformatics/btq683. [DOI] [PubMed] [Google Scholar]
  • 11.Boetzer M, Pirovano W. 2012. Toward almost closed genomes with GapFiller. Genome Biol 13:R56–R56. doi: 10.1186/gb-2012-13-6-r56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bao E, Jiang T, Girke T. 2014. AlignGraph: algorithm for secondary de novo genome assembly guided by closely related references. Bioinformatics 30:i319–i328. doi: 10.1093/bioinformatics/btu291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Assefa S, Keane TM, Otto TD, Newbold C, Berriman M. 2009. ABACAS: algorithm-based automatic contiguation of assembled sequences. Bioinformatics 25:1968–1969. doi: 10.1093/bioinformatics/btp347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi: 10.1093/bioinformatics/btu153. [DOI] [PubMed] [Google Scholar]
  • 15.Inouye M, Dashnow H, Raven L-A, Schultz MB, Pope BJ, Tomita T, Zobel J, Holt KE. 2014. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 6:90. doi: 10.1186/s13073-014-0090-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M, Landraud L, Rolain JM. 2014. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 58:212–220. doi: 10.1128/AAC.01310-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, Møller Aarestrup F, Hasman H. 2014. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58:3895–3903. doi: 10.1128/AAC.02412-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. 2011. PHAST: A fast phage search tool. Nucleic Acids Res 39:W347–W352 doi: 10.1093/nar/gkr485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shaw KJ, Rather PN, Sabatelli FJ, Mann P, Munayyer H, Mierzwa R, Petrikkos GL, Hare RS, Miller GH, Bennett P. 1992. Characterization of the chromosomal aac(6′)-Ic gene from Serratia marcescens. Antimicrob Agents Chemother 36:1447–1455. doi: 10.1128/AAC.36.7.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES